- Active dermatology solution for the treatment of rosacea and skin redness.
- Drug free and safe to use.
• SEQuaderma™ is a new treatment option for patients troubled by temporary or background facial redness and thread veins and its use means that patients no longer need to rely on cosmetic creams that simply mask their unwanted redness.
• Being drug free, this product can be used on its own or between courses of drug treatments when the user might otherwise be exposed to relapses. It will not compromise any medication and is suitable for those who may be using pharmaceuticals to manage multiple conditions.
• It has been developed and tested by dermatologists and is suitable for long-term use.
• SEQuaderma™ is proven to be extremely well tolerated.
Mode of Action
• SEQuaderma™ has been clinically proven to treat, rather than to conceal facial redness and to reduce facial flushing and background redness.
• In addition to hydrating the skin, SEQuaderma™ improves peripheral lymph drainage, which is compromised in many skin conditions such as rosacea1, and can lead to accumulation of toxins that result in unwanted redness.
• Since this treatment is not just a concealer, visible reduction in skin redness may take between 2 and 4 weeks of treatment to occur.
In a clinical study, after 4 weeks of SEQuaderma™ treatment2:
• Over 75% of patients treated with SEQuaderma™ showed improvements in a primary or secondary symptom of rosacea.
• In particular, improvements were seen in temporary flushing, background redness and thread veins.
• 35% of patients reported improvements in permanent facial redness.
In addition, a self-perception study was conducted in 101 healthy subjects of different ethnicities3. These subjects with temporary, regular and easy blushing or flushing, and spider veins reported that using SEQuaderma™ for 4 weeks led to the following results:
• 63% reported that their flushing frequency reduced. The majority stated the reduced occurrence and intensity of visible blushing.
• 73% stated a reduction in blood vessel appearance.
• 67% felt the healthy appearance of their skin had increased.
• 77% reported skin less dry/rough to the touch.
• 75% had clearer skin.
• The majority of users agreed the product was the most effective anti-redness serum they had used and they would buy this product instead of their usual product.
Aqua, Phosphatidylcholine, Alcohol, Glycerin, Carbomer, Polysorbate 80, Disodium Phosphate, Sodium Hydroxide, Benzyl Alcohol, Methylparaben, Ethylparaben, Linalool, Disodium EDTA, Sodium phosphate, BHT.
1 Zgraggen S, Ochsenbein AM, Detmar M. An important role for blood and lymphatic vessels in inflammation and allergy. J Allergy 2013;2013:673281.
2 Luger T, Peukert N, Rother M. A multicentre, randomized, placebo-controlled trial establishing the treatment effect of TDT 068, a topical formulation containing drug-free ultra-deformable phospholipid vesicles, on the primary features of erythematotelangiectatic rosacea. J Eur Acad Dermatol Venereol 2015;29:283–290.
3 A user trial study in 101 healthy male and female subjects aged between 20 and 70 years from a breadth of ethnicities. Princeton Consumer Research Report; PROUSE1, 29 May 2015.
How to Use
• Thinly spread a suitable amount over the affected area twice daily.
• Gently tap the product in and leave until it is touch-dry, avoiding applying creams or make-up until dry. SEQuaderma™ is different – the gel has to dry to create the environment that allows the tiny lipid spheres (called Sequessome™ vesicles) in the gel to cross the skin into the tissue below.
• If necessary, any residue can be wiped or washed off.
• If using alongside other topical medications or other SEQuaderma™ products, first apply SEQuaderma™, wait for about 5-10 minutes, wipe off any residue and then continue with your other treatments.
• Avoid getting the products in the eyes, but if this does happen, rinse with plenty of cold water.
• Do not use if hypersensitive to any of the ingredients.
• Once open, use within 3 months.
• Regular twice-a-day application provides at least 2 weeks of treatment, depending on the size of the area being treated.